Sysoliatina N A
Farmakol Toksikol. 1982 Jul-Aug;45(4):41-6.
It has been shown that a single intravenous injection of obsidan (0.1 mg/kg) to dogs during acute coronary occlusion results in a decrease in the activities of "a" phosphorylase, Mg-dependent ATPase, creatine phosphokinase, succinate dehydrogenase and cytochrome-c-oxidase, in a slight lowering of the ATP content accompanied by the increased content of AMP and unchanged concentration of creatine phosphate. Repeated injections of the drug in the same dose raise the activities of the enzymes up to the control level and produce activation of glycogenolysis and succinate dehydrogenase during the reparative period. The drug favours the preservation of "b" phosphorylase activity in the infarcted tissue and does not change the content of adenine nucleotides and creatine phosphate upon prolonged application.
已经表明,在急性冠状动脉闭塞期间,给狗单次静脉注射黑曜石(0.1毫克/千克)会导致“a”磷酸化酶、镁依赖性ATP酶、肌酸磷酸激酶、琥珀酸脱氢酶和细胞色素c氧化酶的活性降低,ATP含量略有下降,同时AMP含量增加,磷酸肌酸浓度不变。以相同剂量重复注射该药物可使酶的活性提高到对照水平,并在修复期激活糖原分解和琥珀酸脱氢酶。该药物有利于梗死组织中“b”磷酸化酶活性的保留,长期应用时不会改变腺嘌呤核苷酸和磷酸肌酸的含量。